172 active
/
697 total (since 2015)
19
Phase 1 Active
155 total
73
Phase 2 Active
229 total
52
Phase 3 Active
206 total
37
Phase 4 Active
140 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
AstraZeneca 14 71 6
GSK 6 46 5
Sanofi 6 14 0
Guangdong Hengrui Pharmaceutical Co., Ltd 5 1 0
Inmunotek S.L. 4 0 0
Novartis 3 19 9
Generate Biomedicines 3 0 0
Upstream Bio Inc. 2 1 0
Anhui Palo Alto Pharmaceuticals, Inc. 2 1 0
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 2 0 0
Oneness Biotech Co., Ltd. 2 0 0
Amgen 2 0 0
Haisco Pharmaceutical Group Co., Ltd. 2 0 0
Chiesi Farmaceutici S.p.A. 1 20 4
Teva Branded Pharmaceutical Products R&D, Inc. 1 10 4
NCT07309614 RECRUITING
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Université de Sherbrooke n=150
NCT06023589 RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
AstraZeneca n=231
NCT07444567 NOT YET RECRUITING
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
AstraZeneca n=230
NCT07359846 RECRUITING
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Generate Biomedicines n=786
NCT06664619 RECRUITING
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Teva Branded Pharmaceutical Products R&D, Inc. n=724
NCT05562466 RECRUITING
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Novartis Pharmaceuticals n=200
NCT07276724 RECRUITING
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Generate Biomedicines n=786
NCT06502366 ACTIVE NOT RECRUITING
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
AstraZeneca n=422
NCT06471257 RECRUITING
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
AstraZeneca n=790
NCT06052267 RECRUITING
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Teva Branded Pharmaceutical Products R&D LLC n=2,700
NCT07363642 RECRUITING
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
AstraZeneca n=400
NCT06307665 RECRUITING
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca n=440
NCT05692180 RECRUITING
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
AstraZeneca n=200
NCT05776927 NOT YET RECRUITING
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Novartis Pharmaceuticals n=304
NCT06473779 ACTIVE NOT RECRUITING
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
AstraZeneca n=296
NCT07372287 NOT YET RECRUITING
A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. n=230
NCT06191315 RECRUITING
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Sanofi n=90
NCT07318350 NOT YET RECRUITING
Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)
Eurofarma Laboratorios S.A. n=174
NCT06323213 RECRUITING
Efficacy and Safety Study of 610 in Patients With Severe Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. n=480
NCT07302516 NOT YET RECRUITING
Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
Qilu Pharmaceutical Co., Ltd. n=636
NCT06750289 RECRUITING
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
AstraZeneca n=400
NCT06223828 RECRUITING
Azithromycin for Critical Asthma - Pediatrics
Johns Hopkins All Children's Hospital n=100
NCT06653322 RECRUITING
A Multi-centered,Randomized,Double-blind,Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
Guangdong Hengrui Pharmaceutical Co., Ltd n=400
NCT06465485 ACTIVE NOT RECRUITING
STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma
AstraZeneca n=504
NCT05757102 RECRUITING
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
GlaxoSmithKline n=292
NCT06560255 RECRUITING
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Professor Klaus Bønnelykke n=2,000
NCT06570889 RECRUITING
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Professor Klaus Bønnelykke n=2,000
NCT07098403 RECRUITING
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
Guangdong Hengrui Pharmaceutical Co., Ltd n=408
NCT05748600 ACTIVE NOT RECRUITING
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
Areteia Therapeutics n=600
NCT04651777 ACTIVE NOT RECRUITING
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
Dr. Grace Parraga n=31
NCT06721247 ACTIVE NOT RECRUITING
Oral Intake of Mg in Controlled Asthmatic Patients
Zagazig University n=166
NCT05251402 ACTIVE NOT RECRUITING
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern
University of Illinois at Chicago n=323
NCT07013123 NOT YET RECRUITING
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
University Hospital, Montpellier n=38
NCT06895460 NOT YET RECRUITING
A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)
The First Affiliated Hospital with Nanjing Medical University n=198
NCT06488755 RECRUITING
SIM0718 Treatment of Asthma Clinical Study
Simcere Pharmaceutical Co., Ltd n=418
NCT04898283 RECRUITING
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Inmunotek S.L. n=180
NCT04435990 RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Inmunotek S.L. n=150
NCT04891237 RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Inmunotek S.L. n=180
NCT06955559 NOT YET RECRUITING
Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children
Assiut University n=60
NCT06837922 RECRUITING
Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Shanghai Mabgeek Biotech.Co.Ltd n=504
NCT04699604 RECRUITING
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)
Bridgette Jones n=300
NCT06829784 RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. n=660
NCT06740045 NOT YET RECRUITING
Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma
Dr. Andrew Thamboo, MD n=10
NCT06618105 NOT YET RECRUITING
Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd
Macleods Pharmaceuticals Ltd n=144
NCT05651841 RECRUITING
REVErsing Airway Remodelling With Tezepelumab
University Hospital, Montpellier n=90
NCT05761028 RECRUITING
A Study of CM310 in Subjects With Moderate to Severe Asthma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. n=600
NCT05641272 NOT YET RECRUITING
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Inmunotek S.L. n=90
NCT03667651 ACTIVE NOT RECRUITING
The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants
University of Melbourne n=760
NCT06261957 COMPLETED
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
GlaxoSmithKline n=477
NCT05850494 COMPLETED
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
AstraZeneca n=52
NCT05202262 COMPLETED
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
AstraZeneca n=645
NCT05755906 COMPLETED
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
AstraZeneca n=374
NCT05555290 COMPLETED
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction
AstraZeneca n=190
NCT05243680 COMPLETED
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
GlaxoSmithKline n=641
NCT03226392 COMPLETED
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Novartis Pharmaceuticals n=704
NCT02892344 COMPLETED
Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma
Novartis Pharmaceuticals n=802
NCT03215758 COMPLETED
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Novartis Pharmaceuticals n=675
NCT05280418 COMPLETED
Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma
McMaster University n=27
NCT05735431 WITHDRAWN
Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil
Eurofarma Laboratorios S.A.
NCT05763121 TERMINATED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
Areteia Therapeutics n=1,061
NCT05813288 TERMINATED
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Areteia Therapeutics n=654
NCT06388889 TERMINATED
Phase III Long-Term Extension Study With Dexpramipexole
Areteia Therapeutics n=509
NCT05274815 COMPLETED
Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
AstraZeneca n=305
NCT03560466 COMPLETED
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
Sanofi n=378
NCT06264674 COMPLETED
Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).
Chiesi Farmaceutici S.p.A. n=836
NCT04718389 COMPLETED
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
GlaxoSmithKline n=1,719
NCT03015610 COMPLETED
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
Jason Lang, M.D., M.P.H. n=41
NCT05292586 COMPLETED
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
Chiesi Farmaceutici S.p.A. n=1,377
NCT06245551 COMPLETED
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma
AstraZeneca n=64
NCT05191186 COMPLETED
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
Aarhus University Hospital n=450
NCT04937387 COMPLETED
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
GlaxoSmithKline n=359
NCT05505734 COMPLETED
A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
Bond Avillion 2 Development LP n=2,516
NCT06154304 COMPLETED
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Cipla Ltd. n=120
NCT03927157 COMPLETED
Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma
AstraZeneca n=405
NCT03248128 COMPLETED
Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
GlaxoSmithKline n=906
NCT03365687 COMPLETED
Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers
Professor Francine Ducharme n=323
NCT04609904 COMPLETED
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
AstraZeneca n=2,187
NCT04609878 COMPLETED
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
AstraZeneca n=2,274
NCT05398263 TERMINATED
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
AstraZeneca n=125
NCT06869798 COMPLETED
EFFECTIVENESS of ZINC AS an ADJUVANT to STANDARD THERAPY VERSUS STANDARD THERAPY ALONE in CHILDREN
King Edward Medical University n=84
NCT04669288 TERMINATED
AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department
University of Arizona n=840
NCT04233190 COMPLETED
A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment
Eurofarma Laboratorios S.A. n=472
NCT04719832 COMPLETED
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
GlaxoSmithKline n=395
NCT04718103 COMPLETED
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
GlaxoSmithKline n=397
NCT06657066 COMPLETED
EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA
King Edward Medical University n=74
NCT06626620 COMPLETED
Randomized Controlled Trial of Intravenous Magnesium Sulfate Versus Terbutaline for Children in the Management of Acute Exacerbation of Asthma
Muhammad Aamir Latif n=120
NCT03562195 COMPLETED
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
GlaxoSmithKline n=300
NCT06461949 WITHDRAWN
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
National Institute on Deafness and Other Communication Disorders (NIDCD)
NCT03000413 COMPLETED
Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial
Hospital Nossa Senhora da Conceicao n=45
NCT02741271 COMPLETED
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
Organon and Co n=181
NCT03186209 COMPLETED
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
AstraZeneca n=695
NCT03137303 COMPLETED
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
University of Illinois at Chicago n=402
NCT04886999 COMPLETED
Study in Adult Patients With Moderate to Severe Asthma
Chiesi Farmaceutici S.p.A. n=78
NCT03338205 WITHDRAWN
The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
Augusta University
NCT03341403 COMPLETED
Effect of a Synbiotic "Probiotical®/Bactecal® " in Asthma
University of Liege n=55
NCT03453112 COMPLETED
Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.
Chiesi Farmaceutici S.p.A. n=494
NCT05322707 COMPLETED
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Cipla Ltd. n=1,485
NCT04705727 TERMINATED
Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation
Centre Hospitalier Intercommunal Creteil n=102
NCT05062759 COMPLETED
Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
AstraZeneca n=70
NCT03706079 COMPLETED
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
AstraZeneca n=951
NCT03557307 COMPLETED
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
AstraZeneca n=598
NCT04305405 COMPLETED
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
AstraZeneca n=30
NCT05813470 COMPLETED
Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma
Cinnagen n=256
NCT03847896 COMPLETED
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
Bond Avillion 2 Development LP n=1,001
NCT04665895 COMPLETED
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma
Respirent Pharmaceuticals Co Ltd. n=451
NCT04265105 COMPLETED
Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults
Royal College of Surgeons in Ireland - Medical University of Bahrain n=18
NCT02192827 COMPLETED
Use of Dexamethasone in Pediatric Asthma Exacerbations
University at Buffalo n=318
NCT03620747 COMPLETED
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
Sanofi n=393
NCT03470311 COMPLETED
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
McMaster University n=20
NCT03884842 COMPLETED
Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.
McMaster University n=24
NCT04259164 COMPLETED
Anti-inflammatory Effects Glycopyrronium
University Medical Center Groningen n=28
NCT03782532 COMPLETED
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
Sanofi n=486
NCT03052725 TERMINATED
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
Teva Branded Pharmaceutical Products R&D, Inc. n=391
NCT03769090 COMPLETED
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
Bond Avillion 2 Development LP n=3,132
NCT03015259 COMPLETED
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
Kindeva Drug Delivery n=1,762
NCT04215848 COMPLETED
As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period
Hat Yai Medical Education Center n=31
NCT04048343 COMPLETED
Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
AstraZeneca n=65
NCT05292976 WITHDRAWN
Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
Aurobindo Pharma Ltd
NCT04049175 TERMINATED
Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma
Chiesi Farmaceutici S.p.A. n=810
NCT04206761 WITHDRAWN
Investigating the Effects of QVM149 on MRI Ventilation Defects
Dr. Grace Parraga
NCT03406078 COMPLETED
Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
AstraZeneca n=150
NCT03347279 COMPLETED
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
AstraZeneca n=1,061
NCT02980133 COMPLETED
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Teva Branded Pharmaceutical Products R&D, Inc. n=841
NCT02513160 COMPLETED
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Teva Branded Pharmaceutical Products R&D, Inc. n=713
NCT02452190 COMPLETED
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
Teva Branded Pharmaceutical Products R&D, Inc. n=468
NCT02501629 COMPLETED
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
Teva Branded Pharmaceutical Products R&D, Inc. n=177
NCT02969408 COMPLETED
A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
Teva Branded Pharmaceutical Products R&D, Inc. n=397
NCT03170271 COMPLETED
A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
AstraZeneca n=660
NCT03468790 COMPLETED
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
Shanghai Biomabs Pharmaceutical Co., Ltd. n=393
NCT03629249 TERMINATED
Systemic Corticosteroids Avoidance Study in Severe Asthma Patients
Novartis Pharmaceuticals n=604
NCT03158311 COMPLETED
Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
Novartis Pharmaceuticals n=1,426
NCT03756883 COMPLETED
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Actavis Inc. n=999
NCT03879837 COMPLETED
Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg
Actavis Inc. n=1,902
NCT02563067 COMPLETED
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
Novartis Pharmaceuticals n=877
NCT02808819 COMPLETED
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
AstraZeneca n=447
NCT02676089 COMPLETED
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)
Chiesi Farmaceutici S.p.A. n=1,433
NCT02676076 COMPLETED
TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA
Chiesi Farmaceutici S.p.A. n=1,153
NCT02924688 COMPLETED
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma
GlaxoSmithKline n=2,436
NCT04124510 TERMINATED
Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy
Mundipharma Korea Ltd n=20
NCT03528577 COMPLETED
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
Sun Pharmaceutical Industries Limited n=128
NCT02821416 COMPLETED
Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics
AstraZeneca n=46
NCT03771040 COMPLETED
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
AB Science n=347
NCT02584257 COMPLETED
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Lupin, Inc. n=217
NCT04051710 COMPLETED
Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH
Aurobindo Pharma Ltd n=1,550
NCT04607629 COMPLETED
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma
AO GENERIUM n=192
NCT03052517 TERMINATED
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
Novartis Pharmaceuticals n=2,538
NCT03133897 TERMINATED
Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study
Children's Hospital of Eastern Ontario n=20
NCT03394989 COMPLETED
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Cipla Ltd. n=1,366
NCT03358147 COMPLETED
Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
Pearl Therapeutics, Inc. n=1,077
NCT02571777 COMPLETED
Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
Novartis Pharmaceuticals n=3,092
NCT03676413 COMPLETED
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Respirent Pharmaceuticals Co Ltd. n=451
NCT03184987 COMPLETED
A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma
GlaxoSmithKline n=111
NCT02555683 COMPLETED
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
Novartis Pharmaceuticals n=894
NCT02483975 COMPLETED
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
GlaxoSmithKline n=111
NCT03100825 COMPLETED
A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
Novartis Pharmaceuticals n=96
NCT02554786 COMPLETED
A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma
Novartis Pharmaceuticals n=2,216
NCT03100500 COMPLETED
A Long-term Safety Study of QMF149 in Japanese Participants With Asthma
Novartis Pharmaceuticals n=51
NCT02555371 COMPLETED
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
GlaxoSmithKline n=306
NCT03562949 TERMINATED
A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
Amneal Ireland Limited n=761
NCT03014674 COMPLETED
A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug
GlaxoSmithKline n=246
NCT02495168 COMPLETED
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
Actavis Inc. n=1,714
NCT02869438 COMPLETED
A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
AstraZeneca n=233
NCT02528214 COMPLETED
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
Sanofi n=210
NCT02902809 TERMINATED
A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
AstraZeneca n=28
NCT02624505 COMPLETED
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Cipla Ltd. n=110
NCT03834012 WITHDRAWN
Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma
Adamis Pharmaceuticals Corporation
NCT03835871 WITHDRAWN
Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma
Adamis Pharmaceuticals Corporation
NCT02853578 SUSPENDED
Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled
Ache Laboratorios Farmaceuticos S.A. n=80
NCT02496715 WITHDRAWN
Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics
Actavis Inc.
NCT03505489 COMPLETED
The Effect of Deep Inhalation on Mannitol Responsiveness
University of Saskatchewan n=26
NCT03816267 COMPLETED
Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children
Suez Canal University n=60
NCT03376932 WITHDRAWN
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
GlaxoSmithKline
NCT02281357 COMPLETED
Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma
AstraZeneca n=140
NCT02725008 COMPLETED
Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation
Geoffrey W Jara-Almonte n=99
NCT03137784 COMPLETED
Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
Novartis Pharmaceuticals n=148
NCT02446418 COMPLETED
A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
GlaxoSmithKline n=423
NCT02918071 COMPLETED
Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home
AstraZeneca n=121
NCT02814643 COMPLETED
Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
AstraZeneca n=103
NCT02414854 COMPLETED
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
Sanofi n=1,902
NCT02753712 COMPLETED
A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma
Mundipharma Research Limited n=105
NCT02301975 COMPLETED
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
GlaxoSmithKline n=1,526
NCT02417961 COMPLETED
Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home
AstraZeneca n=162
NCT02546869 WITHDRAWN
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Hoffmann-La Roche
NCT02559791 COMPLETED
Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
McMaster University n=10
NCT02596321 COMPLETED
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
Abbott n=112
NCT02230332 COMPLETED
Alendronate to Prevent Loss of Bronchoprotection in Asthma
Milton S. Hershey Medical Center n=78
NCT03372473 COMPLETED
Montelukast and Loratadine in Children With Asthma
Innovacion y Desarrollo de Estrategias en Salud n=80
NCT02502734 COMPLETED
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
GlaxoSmithKline n=60
NCT02322775 COMPLETED
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
AstraZeneca n=211
NCT02594332 TERMINATED
Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
Johannes Gutenberg University Mainz n=29
NCT02725242 COMPLETED
Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma
Hat Yai Medical Education Center n=77
NCT02322788 COMPLETED
Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3
AstraZeneca n=95
NCT02371993 COMPLETED
Asthma in the Elderly: A Study of Choline Supplementation
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. n=30
NCT02127697 WITHDRAWN
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
Novartis Pharmaceuticals
Data: ClinicalTrials.gov